Images have been removed from the PowerPoint slides in ... · Torsades de Pointes. Practice Alert -...
Transcript of Images have been removed from the PowerPoint slides in ... · Torsades de Pointes. Practice Alert -...
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20171
CCRN Review – Cardiovascular
Cleo Bonham, MSN, RN, CCRN
CCRN Review – Cardiovascular
• Cardiovascular (18% CCRN) (33% PCCN)
• General KnowledgeLooks at concepts related to disease and injury. Looks at nursing actions and judgements.
Coronary Arteries
• Right Coronary Artery
Supplies: Left Ventricle
Inferior Wall
Posterior Wall
Right Ventricle
SA Node (55%)
AV Node (90%)
Coronary Arteries
• Left Main Coronary ArteryLeft Anterior Descending
Left VentricleAnterior WallVentricular Septum
CircumflexLeft Ventricle
Lateral Wall
The Cardiac Anatomy in Relation to Coronary Arteries – Anterior View
The Cardiac Anatomy in Relation to Coronary Arteries – Posterior View
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20172
Electrode Placement AACN Procedure Manual
• Limb leads (I,II,III)• Place to decrease muscle artifact during limb movement
• Placement• Right Arm (RA) infra-clavicular fossa close to right
shoulder• Left Arm (LA) infra-clavicular fossa close to left shoulder• Left Leg (LL) below rib cage on left side of abdomen• Ground (RL)
• Precordial Leads - depends on patient’s needs
Practice Alert - ST Segment Monitoring7
5 Lead Electrode Placement
5 lead systems allow for the recording of any of the six limb leads plus one precordial (V) lead.
Shown lead placement for recording V1 or V6.
5 Lead monitoring systems are recommended over 3 lead systems for monitoring QRS morphology
Practice Alert - Dysrhythmia Monitoring8
Lead Selection
• Monitoring ST segment changes in 12 leads provides the most accurate data for identification of ischemic events.
• If only two leads are available for ST segment monitoring, use leads III and V3 (unless otherwise indicated)
Practice Alert - ST Segment Monitoring9
ST Segment Fingerprint
• If 12 lead monitoring is not available, use the patient’s “ST Fingerprint”.
• Defined as the pattern of ST segment elevation and/or depression unique to a particular patient based on the anatomic site of coronary occlusion
• Can be obtained during STEMI or PCI
Practice Alert - ST Segment Monitoring
10
Other Considerations
• If the ST fingerprint is not known, use leads III and V3.
• For patients without definitive ACS, with suspected of having or being ruled out for ACS, use leads III and V5.
• For non-cardiac surgical patients lead V5 is valuable for identifying demand-related ischemia.
Practice Alert - ST Segment Monitoring
11
12 Lead Review
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20173
Cause for Concern
• ST depression or elevation of 1-2 mm that lasts for at least one minute can be clinically significant and warrants further patient assessment.
Practice Alert - ST Segment Monitoring
13
Flanders SA. Continuous ST-segment monitoring: Raising the bar. Crit Care Nurs Clin N Am 2006;18(3):172
Alarm Parameters
• Patients at high risk for ischemia• Set ST segment alarm parameters 1
above and below baseline ST segment
• Stable Patients• Set ST segment alarm parameters 2
mm above and below baseline ST segment
Practice Alert - ST Segment Monitoring14
Patient Positioning
• Evaluate ST segment with the patient in the supine position.
• Change in body position can alter ST segment, mimic ischemia.
• If ST alarm sounds with patient in side-lying position, return patient to supine. If deviation persists in supine may indicate ischemia.
Practice Alert - ST Segment Monitoring15
Acute Coronary Syndromes
• Unstable angina
• Chest pain without increase in cardiac enzymes
Pain in Acute Coronary Syndrome
ChestNeck and/or jaw
Arms (left more common than right)
Epigastric and abdominal
Back
Pathways to Thrombosis
Placque rupture vessel
injury
Thrombosis
Red Clot Pathway
White Clot Pathway
Platelet activation and fibrinogen binding
Fibrinogen
Von Willebrand factor & Collagen
Platelet adhesion
Tissue factor/VIIa complex
Xa
FibrinPlatelet aggregation
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20174
Acute Coronary Syndromes
• Ischemia• Injury
• Infarction
12‐Lead ECG Variations in AMI and Angina
Baseline
Ischemia—tall or inverted T wave ST segment may be depressed
Injury—elevated ST segment, T wave may invert
Infarction (Acute)—abnormal Q wave,ST segment may be elevated and T wavemay be inverted
Infarction (Age Unknown)—abnormal Q wave,ST segment and T wave returned to normal
T wave inversionAcute Coronary Syndromes
Non ST elevated Myocardial Infarction (NSTEMI)
Acute Coronary Syndromes
ST Elevated Myocardial Infarction - STEMI
Acute Coronary Syndromes
• 12 lead analysis
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20175
Normal EKG Anterior‐Lateral MI
Lateral MI Inferior MI
Inferior Posterior MI Right Ventricular MI
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20176
RV Infarct
• 50% of inferior MI patients, 10 – 15% will have hemodynamic compromise. mortality. Associated with SA and AV conduction issues
• Hemodynamics: preload, RV and RA compliance. BP and atrial kick
• Treatment Options: colloids and crystalloids to PAW to 15-20. Add Dobutamine. Maintain AV synchrony. NO NTG!
Practice Question
12 lead ECG that shows Q waves and ST elevation in leads V2 through V4 indicates:
A. Occlusion of the left anterior
descending B. Occlusion of the circumflexC. Occlusion of the right coronaryD. Prinzmetal’s angina (coronary spasm)
Practice Question
Which of the following 12 lead ECG changes would be expected in a patient having an acute inferior MI?
A. Q waves, ST elevation & inverted T waves in V4-V6, I and aVL
B. Q waves in aVL, I, and all precordial leads and ST elevation in II and III
C. Deep Q waves, ST elevation and inverted T waves in II, III and aVF
D. Deep Q waves, ST depression and T wave elevation in II, III and aVL
Practice Question
A patient is admitted to the ICU c/o chest pain and nausea. The ECG monitor reveals second degree AV block, Type II. These findings are probably the results of occlusion of which of the following coronary arteries?A. Left Anterior DescendingB. Left circumflex
C. Left mainD. Right
QT Interval
• Approximate measure of the duration of ventricular repolarization.
• Measured from the beginning of the Q wave to the end of the T wave
• Varies with heart rate• Lengthens with bradycardia• Shortens with tachycardia
Practice Alert -Dysrhythmia 35
QT Interval
Practice Alert -Dysrhythmia Monitoring36
Measure from beginning of the QRS complex to the end of the T wave
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20177
QTc Interval
• QT interval corrected for heart rate (QTc)• Formula for calculating QTc (Bazett’s formula)
• QTc > 0.50 seconds considered dangerously prolonged and is associated with a higher risk of Torsades de Pointes.
Practice Alert -Dysrhythmia
Monitoring37
Acute Coronary Syndromes
• Interventions• Cath lab procedures – Diagnostic vs Interventional
• Diagnostic – Right sided heart cath • Insertion of a Pulmonary Artery catheter• Measures pressure on right side
Acute Coronary Syndromes
Interventional
• PCI – Balloon angioplasty, Stents
Cardiac Surgery
CABG
Cardiac Surgery
Valve SurgeryMitral
Aortic
Types of valves – MechanicalCadaver
Animal
Minimally Invasive Cardiac Surgery• Trans-aortic Valve Replacement (TAVR)
• Balloon Valvuloplasty
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20178
Acute Coronary Syndromes
• Complications• Hypotension• Bradycardia• Papillary muscle rupture
Complications: With or Without Trauma
Cardiac rupture, ventricular septal defect,and papillary muscle rupture
Signs and symptoms include:• New murmur• Acute decompensation• Cardiogenic shock• Death
Treatment: Emergency Surgery
Cardiogenic Shock
• High mortality• Occurs in 10 – 15% of all MI’s
• Also, post CABG, papillary muscle rupture, acute VSD, end stage valve disease, coarctation of the aorta, pericardial tamponade
Cardiogenic Shock Signs & Symptoms• CI < 2.0, MAP 60, SBP 80, thready pulses, cap
refill > 2 seconds, SVR > 1200 dynes, UO (< 30cc/hr)
• LOC, restless, confused, agitated, • bowel function • Cold, clammy, mottled skin• Hypoxia, with respiratory symptoms
• Metabolic acidosis (poor prognosis with lactic acidosis > 4 mmol/l)
Cardiogenic Shock
• Treatment: contractility afterloadImprove oxygenationMaintain preload tissue O2 demands
IABP Therapy
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 20179
IABP Therapy
• Circulation is augmented or increased
• Ventricular workload is reduced
IABP Therapy
• Balloon inflation upon closure of the aortic valve or diastole
• Balloon deflation before systole or ventricular ejection
IABP Therapy
• Inflation: Increased aortic diastolic
pressureIncreased coronary perfusionIncreased systemic perfusion
IABP Therapy
• Deflation:Decreased aortic pressureDecreased afterloadDecreased myocardial oxygen
consumptionIncreased stroke volume
IABP Therapy ‐ Complications
Dissection of femoral arteryEmbolization to LE – the 6 P’s
Pain (Isometric), paresthesia, pallor, polar, paralysis, pulseless
Hemorrhage at insertion siteInfectionPerforation of the aortaArterial obstruction (femoral, mesenteric, renal subclavian)CoagulopathyThrombosis
PRACTICE QUESTION
The primary purpose of the IABP is to decrease:A. Stroke volume index
B. AfterloadC. Coronary perfusion pressureD. Ejection fraction
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201710
PRACTICE QUESTION
Which of the following is a contraindication to IAB counterpulsation?A. Aortic valve insufficiency
B. Mitral valve regurgitationC. Ventricular aneurysmD. Ventricular septal defect
PRACTICE QUESTION
A patient with unstable angina has an IABP inserted. Hemodynamics are: HR = 148 (Sinus tachycardia); MAP = 40 mm Hg; PCWP = 25 mm Hg; CI = 1.4 L/min.Which of the following should be included in this patient’s plan of care?
A. Check the timing of the IABP, decreasing balloon inflation frequency to 1:2
B. Stat echo, lasix, check balloon timingC. Dobutamine, 12 lead EKGD. Adenosine, stat Hgb & Hct, dobutamine
Heart Failure ‐ AHA 2015 Statistics
• About 6 million Americans
• 870,000 new cases each year
• 1 in 9 deaths related to HF
• Almost 1 million hospitalizations each year (cost of approx. $15.6 Billion)
• 50% die within 5 years of HF diagnosis
• Current mortality rate >57,000 / year
• Prevalence: men>women (all ages); Almost 20% of population >75
• Most common DRG for patient > age 65
Etiology and Diagnosis
• Heart failure is a set of clinical signs and symptoms that follow injury to or dysfunction of the myocardium
• Cardiac Output is insufficient to meet the metabolic needs of the body tissues
• Due to failure of the heart as a pump (MI, structural defects, cardiomyopathy, valve disease, arrhythmias)
• Or to excessive metabolic demands, eg thyroid crisis
• Failure of compensatory mechanisms to preserve CO
Symptoms:
• Shortness of breath
• Crackles • Edema • Fatigue or poor exercise tolerance
New York Heart Assn Classification
Functional Capacity Objective Assessment
Class I: No symptoms with normal activity
No objective evidence of cardiovascular disease
Class II: Symptoms with ordinary activity
Evidence of minimal cardiovascular disease
Class III: Symptoms with less than ordinary activity
Objective evidence of moderately severe cardiovascular disease
Class IV: Symptoms at rest Evidence of severe cardiovascular disease.
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201711
Two common ways of describing heart failure:
1.Left sided heart failure versus right sided heart failure
2.Systolic versus diastolic
Left sided heart failure vs right‐sided heart failure
• Left-sided heart failure• Cardiac output decreases • Pressure in the LV, left atrium and pulmonary rises • Leads to pulmonary congestion,• Demonstrated as dyspnea and fatigue.
Left sided heart failure vs right‐sided heart failure• Right-sided heart failure
• leads to similar problems in the systemic venous circulation
• neck distension • peripheral edema (and consequent weight gain)• engorgement of the hepatic and gastric vessels
Systolic versus diastolic* Systolic• Systolic – most common type – occurs in about 2/3
of patients with HF• Chronic volume overload
• Distended left ventricle • Elevated LV end diastolic volume• Decreased cardiac output• Decreased ejection fraction; EFs less than 40%,
sometimes as low as 15-20%
Systolic versus diastolic* Diastolic• Stiff left ventricle that cannot fill adequately with
normal filling pressures • Decreased LV end diastolic volume
• Normal to elevated ejection fraction
Systolic versus Diastolic
Systolic Diastolic
S3 gallop S4 Gallop
Solid Tx guidelines Tx guidelines lacking
Poor prognosis Better prognosis
Large dilated heart Small or normal size heart, thicken left ventricle
BP low to normal BP Elevated
EF < 40% EF Normal or > 40%
Less common in women More common in women
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201712
Pathophysiology
• Three neurohormonal responses occur to help body try to compensate.
1. Sympathetic nervous system stimulation
2. Renin-angiotensin-aldosterone activation
3. Ventricular remodeling
Sympathetic nervous system stimulation• Baroreceptors stimulate the medulla • Catecholamines are released causing
vasoconstriction and increased heart rate
• Sympathetic nervous system stimulation can trigger arrhythmias and sudden death
• Sinus tachycardia is a compensatory mechanism, used to increase cardiac output
Renin‐angiotensin‐aldosterone activation• Promotes fluid retention.• Angiotensin II is a potent vasoconstrictor which
increases BP and afterload.
• Aldosterone causes sodium and water retention.
Ventricular Hypertrophy
Ventricular remodeling
• Cardiac cells (myocytes) change configuration• Hypertrophy yields large abnormal cells that do not
contract as efficiently
• Shape of the ventricle changes, increases muscle mass and impairs contractility
• Myocardial oxygen demand increases with increased size
Apoptosis
• Preprogrammed cell death without inflammation or scarring
• Certain neurohormones such as angiotensin II and catecholamines promote apoptosis
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201713
Neurohormones
• Atrial natriuretic peptide (ANP)
• Brain natriuretic peptide (BNP)
Neurohormones
• Both ANP and BNP promote vasodilatation, reduce sodium and water retention, and inhibit sympathetic tones
• Limit cardiac hypertrophy and remodeling
Neurohormones
• Nesiritide is a commercially prepared form of BNP
• Given IV for severe decompensated HF
Neurohormones
• BNP Test is used for patients that present to Emergency Room with shortness of breath
• Test helps differentiate between HF and respiratory problems such as COPD or pneumonia
• Results in 15 minutes
BNP Results
• BNP< 100 pg/ml, not heart failure• BNP 100 – 250 pg/ml. probably heart failure,
compensated
• BNP > 500 decompensated heart failure• BNP > 1000, only due to heart failure
N‐Terminal proBNP (NT‐proBNP)
• Age related
• Age < 50 450 pg/ml• Age 50-75 900 pg/ml• Age > 75 1800 pg/ml
On average a 5-10 fold increase over previous measures.
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201714
BNP Questions
The main stimulus for BNP production is :
A.aldosterone production.B.fluid overload.C.kidney failureD.increased myocardial wall stretch.
BNP Questions
Which of the following factors can affect the sensitivity and specificity of BNP for the diagnosis of HF?
A. Patient’s age
B. Severity of HFC. Cut-off value usedD. Type of ventricular dysfunction
E. All of the above.
BNP Questions
Higher BNP levels are associated with increased mortality independent of age, NYHA class, prior MI, or LVEF.A. True
B. False
Treatments: Pharmacological
• Diuretics • Angiotensin Converting Enzyme (ACE) Inhibitors – often
given in conjunction with the diuretics.
captopril, enalapril, lisinopril
Treatments: Pharmacological
• Beta-Adrenergic Blockers – use in combination with diuretics and ACE-Inhibitors
• For NYHA class I through III heart failure
• Do not use with class IV heart failure, asthma or other pulmonary disease, or severe bradycardia or conduction problem
• Carvedilol, metoprolol - only two FDA approved for HF
Treatments: Pharmacological
• Angiotensin II Blockers – usually used if patient cannot take ACE – Inhibitors
• Losartan, valsartan
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201715
Treatments: Pharmacological
• Vasodilators
• isosorbide
Treatments: Pharmacological
• Positive inotropic agents
• Dobutamine, usually used for short term therapy• Milrinone (a phosphodiesterase inhibitor• Nesiritide – acute only, not long term
Treatments: Pharmacological
Calcium Channel Blockers
• Amlodipine, felodipine
Treatments: Ultrafiltration
• Therapy to remove excess salt and water from patients with fluid overload.
• Adjunct to diuretics or when diuretics fail to work effectively. (Hold diuretics during the procedure.)
• Removes isotonic fluid therefore removes more sodium than diuretics.
Treatments: Ultrafiltration
• Left sided failure• Typically pull 250 cc/hr for 24 hours• (6 Liters)
• Right side failure• Typically pull 100 cc/hr
Treatments: Mechanical
• Pacers –Dual chamber, biventricular
• VADs – Ventricular assist device• Bridge to transplant or destination therapy
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201716
Biventricular Pacemaker Acute Pulmonary Edema
• Cardiogenic vs Noncardiogenic• BNPs can assist in diagnosis
• Cardiogenic – Left ventricular failure• Noncardiogenic – Pulmonary issue such as ARDS
Cardiomyopathy
• Definition• Any heart muscle disease of unknown origin
• Structural or functional abnormality
• Primary or secondary
Primary Cardiomyopathy
• Unknown cause
• Only myocardium is affected
Secondary
• Caused by another condition
• Examples: Ischemia, ETOH, AIDS, pregnancy
Types of Cardiomyopathies
• Dilated
• Hypertrophic
• Restrictive
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201717
Dilated Cardiomyopathies
• Most common type
• Problem with contraction
• Progressive deterioration
Dilated – 4 Dominant Features
• Ventricular dilation• Impaired systolic function
• Atrial enlargement• Stasis of blood in the left ventricle
Dilated Cardiomyopathy –Physical Findings• S3, S4
• Narrow pulse pressure (difference between systolic and diastolic pressures)
If all else fails…..
• Possible candidate for transplant
Hypertrophic Cardiomyopathy
• 4 Dominant features• Ventricular hypertrophy• Rapid contraction of left ventricle• Impaired relaxation• Intracavity systolic pressure gradient
Dilated vs. Hypertrophy
• Dilated cardiomyopathy• Problem with contraction
• Hypertrophic cardiomyopathy• Problem with relaxation
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201718
Hypertrophic Cardiomyopathy
•Clinical presentation• Dyspnea, fatigue, angina, syncope• Some people are asymptomatic• Sudden death – teens and young adults
Hypertrophic Cardiomyopathy‐Physical Findings• Systolic murmur• Abrupt arterial pulses
• Split S2• S3, S4
Surgical Treatments
• Septal Myotomy
Restrictive Cardiomyopathy
• Least common type
• Abnormality of relaxation
Clinical Presentation
Dyspnea, fatigue, angina, syncope
Exercise intolerance
Physical Findings
• Peripheral Edema• Elevated CVP
• Ascites• S3, S4
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201719
Pericarditis
• ECG Changes• ST segment normal in V1 and aVR but all other leads
show ST elevation• PR Interval depression in limb leads and V5, V6
• Decrease in if pericardial effusion is present
Pericarditis
Valvular Heart Disease
• Structural or functional abnormalities• Stenosis - narrowed valve
• Regurgitation - backflow of blood through valve
• Mitral• Aortic
• Tricuspid (rarely isolated)
Myocardial Conduction System Defects• AV Blocks
• 1st degree
- 2nd degree type I• 2nd degree type II• 3rd degree (complete)
Review of AV Blocks – 1st Degree• Prolonged PR Interval
• Greater than 0.20 sec• Every P wave is followed by a QRS
Review of AV Blocks 2nd degree type 1 (Wenckebach)
Progressively longer PR intervals until one P wave does not produce a QRS.
Irregular rhythmP waves are regular QRS waves are irregular
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201720
Review of AV Blocks 2nd degree type 2 (Mobitz)
Intermittent conduction of P waves to the AV node.
Some P waves produce a QRS, some don’t.
PR intervals are all the same when the impulse does get through the AV node.
Review of AV Blocks 3rd degree (Complete Heart Block)
• No correlation between the P waves and the QRS waves
• Atria and ventricles are beating independently
• P waves are regular, QRS waves are regular
Myocardial Conduction System Defects
• Bundle Branch Blocks - Right or Left• Left anterior or left posterior hemiblocks
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201721
Left Anterior Hemiblock
Characteristic EKG changes
• Marked left axis deviation• Normal QRS width• rS complex in leads II, III, aVF• qR complex in leads I, aVL (not essential for
diagnosis)
Left Posterior Hemiblock
Characteristic EKG changes• leads I and aVL, you see rS pattern
• leads II, III, aVF, you see a qR pattern• Right axis deviation• Usually normal QRS duration
Posterior Hemi-block
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201722
Hypertensive Crisis ‐ Etiologies
• UNTREATED OR UNCONTROLLED HYPERTENSION.
• POOR COMPLIANCE WITH PRESCRIBED MEDICATION REGIMEN
• SUDDEN DISCONTINUATION OF
ANTI-HYPERTENSIVE MEDICATION
• DRUGS: COCAINE, AMPHETAMINES, MONO-AMINE OXIDASE INHIBITORS
(ADRENERGIC CRISIS)
Hypertensive Crisis ‐ Etiologies
• Head trauma, stroke, cerebral hemorrhage• Endocrine and Pituitary tumors
• Spinal cord injury• Guillain-Barre Syndrome• Post-operative hypertension• Pre-eclampsia and eclampsia
Hypertensive Crisis ‐ Etiologies
• Renovascular hypertension• Renal disease (acute glomerulonephritis, renal
tumors or occlusion)
• Collagen vascular diseases (Lupus, Scleroderma)
• Severe burns• Adrenocortical hyperfunction
Categories of HTN
• Normal – SBP <120 and DBP <80• Pre-HTN- SBP 120-139 or DBP 80-89
• Stage 1 – SBP 140-159 or DBP 90-99• Stage 2 SBP >160 or DBP >100
Quick review of the Basics:What is Hypertension?
• Hypertension, or high blood pressure, is the chronic state of elevated pressure in the arteries.
• Physiology:• Narrowing of vessels • Fluid retention• Both
• Under normal conditions: Autoregulation of blood pressure is done by release of:
• Endothelins (upward)• Prostacyclin (downward, short
term)• Nitric oxide (longer term)
131
Types of Hypertension
Primary• “Essential hypertension”
• No known cause
• Diagnosed by excluding secondary causes
• Progressive disease
• Incidence: 90-95% of hypertension diagnoses
Secondary• Hypertension caused by another
medical issue, including:• Kidney disease• Thyroid disease
• Appears quickly – controllable by treating underlying condition
• Incidence: 5-10% of hypertensive cases
132
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201723
Hypertensive Crisis has classifications of:1. Malignant Hypertension2. Hypertensive Emergency3. Hypertensive Urgency
Defined as a life-threatening elevation in BP.
Progressive or impending target organ damage.
BP >180/110
Target organs at risk:HeartBrainKidneysOptic nerve
Hypertensive Emergency vs. Urgency• Hypertensive Emergency
• Severe elevations in blood pressure (DBP usually >130)
• Evidence of target organ dysfunction
• Requires immediate controlled BP reduction
Hypertensive Emergency vs. Urgency
• Hypertensive Urgency
• Severe elevations of BP• Without evidence of target organ dysfunction• Requires BP reduction
Differentiating characteristic: Organ damage, not BP level.
Presentation and Treatment of Hypertensive Urgency• Severe elevation in blood pressure without end organ
damage
• Treat on an outpatient basis with oral antihypertensive
• Goal: reduce blood pressure mean by 25% in the first 24 hours
• Example: • BP = 170/105 (127)• 25% reduction: MAP = ?
Presentation and Treatment of Hypertensive Emergency• Severe elevation in blood pressure with end organ
damage• Treat emergently with titratable IV vasoactive
medications.
• Arterial line needed to monitor BP constantly.
Malignant Hypertension
Is a hypertensive emergency.
• Involves very rapidly rising blood pressure
• Results in papilledema (optic nerve swelling)
• Presenting symptoms:• Convulsions• Blurred vision• Headache
• Usually accompanied by other end organ damage:
•Heart failure•Kidney failure•Hypertensive encephalopathy
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201724
Presentation and Treatment of Hypertensive Emergency• Goal: Controlled lowering of blood pressure
• No more than 20% in first hour
• 160/110 (127) in next 2-6 hours
• Reduce MAP by 25% in 8 hours
• Example – CVA that needs thrombolytics
Nitroprusside (Nipride)
Drug Action• Arterial and venous dilator
• Decreases peripheral vascular resistance
• Preload and afterload reducer
• Improves LV function
• Rapid action with short half-life
Nursing Considerations • Arterial line for continuous BP monitoring
• Metabolizes into cyanide• Antidote: Sodium Thiosulfate• Increased risk of cyanide toxicity with renal failure
• Light sensitive: Shield from light
Nitroglycerin
Drug Action• Affects venous dilation
• Arterial dilation at high doses (1 mcg/kg/min)
• Decreases preload and/or afterload
• Response varies with patient’s baseline pressure
• Vasodilates the pulmonary vascular bed
Nursing Considerations • Headache
• Glass bottle requires vented tubing
• Absorbed by some IV tubing: May have increased response to drug when tubing is saturated
Labetalol
Drug Action• Alpha and Beta blocker
• Reduces systemic vascular resistance
• Use in pregnancy
Nursing Considerations • Onset 5-10 minutes
• Taper dose when discontinuing
• Caution with:• Bradycardia, Asthma, A-V Block, Renal impairment
Peripheral Vascular Disease
Vascular disease outside of the heart and brain
Narrowing of vessels carrying blood to:LegsArmsStomachKidneys
Peripheral Vascular Disease
• Two Types• Functional -Example – Raynaud’s disease
• No structural defect in vasculature• Caused by spasm• Short term effects
• Organic - Example – peripheral artery disease
• Structural changes of vasculature• Inflammation• Tissue damage• Atherosclerosis
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201725
Peripheral Vascular Disease
• Incidence• 10 million Americans
• 5 million are asymptomatic• 2.5 million undiagnosed• 2.5 million are treated (2.1 million medically
managed)• Increases with age (1/3 of adults over 70)
Peripheral Vascular Disease
• Symptoms• Claudication• Numbness or tingling in feet• Burning or aching pain• Ischemic ulceration
Peripheral Vascular Disease
• Symptoms• Change in color of skin• Loss of hair on legs• Gangrene
Peripheral Vascular Disease
• Risk Factors• >50 years old• Smoker• Diabetic• High blood pressure• Overweight• High cholesterol, atherosclerosis• Family history
PVD ‐ Diagnostic Tests
• Doppler ultrasound
PVD ‐ Diagnostic Tests
• Angiography
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201726
Ankle‐Brachial Index
• Why is it ordered?• Indicator of arterial occlusion
• How is it calculated?• SBPA /SBPB = ABI• SBPA = 90; SBPB =120; • ABI = 90/120 = 0.75
Ankle‐Brachial Index
How is it interpreted?• ABI= 1-1.3 Normal: No PAD
• ABI = 0.8-0.99 Mild blockage: Beginning PAD• ABI = 0.5-0.79 Moderate blockage: Pain with
exercise• ABI < 0.5 Severe blockage: Pain at rest • ABI < 0.25 Potential for limb loss
PVD – Treatment
• Medical Management• Lifestyle Changes• Pharmacologic
• Aspirin• Clopidogrel or Ticlopidine• Cilostazol• Heparin• Lipid Lowering drugs
PVD – Treatment
• Invasive Procedures• Angioplasty / stents
• Surgery• Atherectomy• Bypass
Treatments:Thrombolytics
• Retavase (Retaplase) or Tenecteplase (TNK)
• Converts plasminogen to plasmin, a natural fibrinolytic
• Thrombolytic drips directly onto the clot
• Heparin infusion also given
• May need additional balloon angioplasty and/or stent
PVD – Treatment
• Surgery is named by artery(s) that are bypassed• Examples – Fem/Fem, Fem/Pop,
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201727
Post‐op Assessment
• Vital signs• Pulmonary
• Fluid Balance (Urine output)• Bedrest• Neurovascular checks
Post‐op Complications
• Graft thrombosis• Hemorrhage
• Edema• Lymphatic Edema• Infection
Graft Thrombosis
• Inadequate arterial flow• Clamp Injury
• Decreased cardiac output• Vasospasm• Thromboemboli
Complications after Reperfusion
• Reperfusion injury• ATN
• Rhabdomyolysis• Tissue breakdown releases myoglobin into plasma• Can overwhelm renal system and lead to kidney failure• Differential diagnosis: CPK > /= 5 times normal• Treatment: Fluid load to maintain urine output of 100 ml/hr.• Alkalinize urine with NaHCO3
• Lactic acidemia
Complications
• Compartment syndrome• Venous thrombosis
• Pulmonary embolus• Graft infection
Graft Infection
• Signs and Symptoms• Incisional swelling• Local tenderness• Drainage• Pulsatile mass• Diminished pulses• Leukocytosis• Fever
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201728
Carotid Artery DiseaseCarotid Artery Disease
• Probable Causes• Atherosclerosis• HTN
Carotid Artery Disease
• Risk Factors• Age
• Hyperlipidemia
• Diabetes
• Hypertension
• Smoking
• Obesity
• Sedentary lifestyle
• Family history of atherosclerosis
Carotid Artery Disease
• Clinical Manifestations• TIA• RIND – Reversible Ischemic Neurological Deficit• Amaurosis fugax – Transient blindness caused by
microemboli to retina
CAD – Diagnostic tests
• Hx and Physical – look for stroke symptoms• Ultrasound
• Arteriography (MRA)
CAD – Treatment
• Lifestyle Modification• Medications
• ASA• Gradual lowering of BP
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201729
CAD Treatment Continued
• Procedures• Carotid Stenting
Combined with medical management:• Aspirin and/or Plavix• Blood Pressure control
CAD Treatments
Surgical
• Carotid Endarterectomy
Post‐op Care
• Watch for potential complications• Hemorrhage (hematoma)
• Causes• Anticoagulation
• Dangers• Obstruction of airway• Sign - Hoarseness
Post‐op Care
• Watch for potential complications• Cranial Nerve damage
FacialGlossopharyngealSuperior LaryngealHypoglossal
Post‐op Care
• Watch for potential complications• Perioperative Stroke• Wound Complications• Recurrent carotid stenosis• Pulmonary complications
Post‐op Care
• Labile Blood Pressure• May have arterial line
• Hypertension• Nipride
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201730
Abdominal Aortic Aneurysm Abdominal Aortic Aneurysm
• Aneurysm Development• Atherosclerosis• Trauma• Arteritis (Infection)• Congenital abnormalities (Marfan’s)
Abdominal Aortic Aneurysm
• Risk Factors• Age• Male• Caucasian• Smoking• Diabetes• Hypertension• Family History
Abdominal Aortic Aneurysm
• Clinical Manifestations• Asymptomatic
• Severe Abdominal Pain
Abdominal Aortic Aneurysm
• Diagnostic Tests• History and Physical
• Echocardiogram
• CT
AAA Treatments
• Monitor
• Surgery• Percutaneous (Closed)
Stent graft• Open
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201731
AAA Post‐op Care
• Systemic Heparinization
• Postoperative Hypertension
AAA Post‐op Care
Post-operative Hypotension• Causes –
• Rewarming• Third spacing of fluids• Blood loss• Cardiac dysfunction
AAA Post‐op Care
• Vasoactive Medications• Dopamine• Nipride• Dobutamine
AAA Post‐op complications
• Cross clamping injuries• Renal failure• Bowel Ischemia
• Small areas to transmural necrosis• Can lead to acute perforation
• Signs/symptoms• pain• diarrhea• abdominal distention• fever
AAA Post‐op complications
Hypo-perfusion of lower extremities
Paralysis
Graft occlusion
Other aortic aneurysms
Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.
CCRN®/PCCN® Review Course - Day 1 ©TCHP Education Consortium, September 2003, Rev. June 201732
References
• Burns, Suzanne AACN Essentials of Critical Care Nursing, 3rd Edition 2014
• Fowler, Leanne Cardiovascular Nursing, 2016
• Urden, Linda et at Priorities in Critical Care Nursing7th Edition 2016